Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Neoplasms | 47 | 2024 | 4282 | 4.010 |
Why?
|
Testicular Neoplasms | 18 | 2024 | 800 | 3.610 |
Why?
|
Carcinoma, Renal Cell | 37 | 2024 | 3186 | 3.300 |
Why?
|
Fallopian Tube Neoplasms | 15 | 2022 | 329 | 2.120 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 10 | 2023 | 483 | 2.000 |
Why?
|
Immunohistochemistry | 53 | 2024 | 11035 | 1.800 |
Why?
|
Teratoma | 8 | 2024 | 402 | 1.740 |
Why?
|
Ovarian Neoplasms | 33 | 2024 | 4904 | 1.730 |
Why?
|
Adenoma, Oxyphilic | 6 | 2024 | 150 | 1.590 |
Why?
|
Cystadenocarcinoma, Serous | 19 | 2018 | 480 | 1.510 |
Why?
|
Perivascular Epithelioid Cell Neoplasms | 4 | 2023 | 78 | 1.500 |
Why?
|
Urinary Bladder Neoplasms | 14 | 2024 | 2184 | 1.500 |
Why?
|
Leiomyomatosis | 2 | 2022 | 69 | 1.480 |
Why?
|
Adenocarcinoma | 15 | 2024 | 6361 | 1.240 |
Why?
|
Genital Neoplasms, Female | 5 | 2021 | 534 | 1.180 |
Why?
|
Paired Box Transcription Factors | 5 | 2013 | 204 | 1.180 |
Why?
|
Prostatic Neoplasms | 26 | 2024 | 11092 | 1.140 |
Why?
|
Uterine Neoplasms | 6 | 2023 | 1425 | 1.140 |
Why?
|
Paget Disease, Extramammary | 2 | 2023 | 50 | 1.110 |
Why?
|
Carcinoma, Transitional Cell | 7 | 2024 | 790 | 1.000 |
Why?
|
Kidney Medulla | 3 | 2021 | 169 | 0.990 |
Why?
|
GATA3 Transcription Factor | 3 | 2024 | 163 | 0.990 |
Why?
|
SOXD Transcription Factors | 2 | 2022 | 44 | 0.980 |
Why?
|
Endodermal Sinus Tumor | 2 | 2022 | 53 | 0.970 |
Why?
|
SOXF Transcription Factors | 1 | 2024 | 31 | 0.940 |
Why?
|
Carcinoma | 8 | 2022 | 2313 | 0.940 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 3 | 2022 | 195 | 0.910 |
Why?
|
Diagnosis, Differential | 28 | 2024 | 12975 | 0.890 |
Why?
|
Metaplasia | 3 | 2021 | 325 | 0.870 |
Why?
|
Neuroectodermal Tumors, Primitive, Peripheral | 2 | 2021 | 43 | 0.850 |
Why?
|
Antigens, Neoplasm | 3 | 2020 | 1996 | 0.830 |
Why?
|
Adenomatoid Tumor | 1 | 2022 | 12 | 0.800 |
Why?
|
Sarcoma | 6 | 2023 | 1801 | 0.800 |
Why?
|
Peritoneal Neoplasms | 4 | 2022 | 706 | 0.770 |
Why?
|
Epithelioid Cells | 1 | 2022 | 61 | 0.770 |
Why?
|
Smooth Muscle Tumor | 2 | 2020 | 64 | 0.770 |
Why?
|
Catenins | 1 | 2021 | 44 | 0.760 |
Why?
|
Seminal Vesicles | 1 | 2021 | 101 | 0.740 |
Why?
|
Endometrial Neoplasms | 7 | 2024 | 1379 | 0.720 |
Why?
|
Melanoma-Specific Antigens | 1 | 2020 | 73 | 0.720 |
Why?
|
Adenocarcinoma, Mucinous | 3 | 2021 | 521 | 0.720 |
Why?
|
Chromosomes, Human, X | 4 | 2015 | 319 | 0.710 |
Why?
|
Neoplasms, Radiation-Induced | 2 | 2021 | 540 | 0.700 |
Why?
|
Carcinoma, Papillary | 4 | 2024 | 786 | 0.700 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 5 | 2022 | 323 | 0.680 |
Why?
|
Uterine Cervical Neoplasms | 5 | 2024 | 2039 | 0.650 |
Why?
|
In Situ Hybridization, Fluorescence | 8 | 2024 | 2510 | 0.650 |
Why?
|
Urothelium | 1 | 2021 | 275 | 0.650 |
Why?
|
Uterine Cervical Dysplasia | 3 | 2013 | 391 | 0.640 |
Why?
|
Stathmin | 3 | 2015 | 70 | 0.620 |
Why?
|
Urethra | 1 | 2020 | 406 | 0.600 |
Why?
|
Ganglioneuroma | 1 | 2018 | 53 | 0.590 |
Why?
|
Plasma Cells | 1 | 2021 | 597 | 0.580 |
Why?
|
Translocation, Genetic | 6 | 2015 | 1392 | 0.570 |
Why?
|
Sex Cord-Gonadal Stromal Tumors | 3 | 2024 | 117 | 0.570 |
Why?
|
Wolffian Ducts | 2 | 2018 | 27 | 0.550 |
Why?
|
Carcinoma in Situ | 6 | 2022 | 777 | 0.530 |
Why?
|
Precancerous Conditions | 5 | 2021 | 975 | 0.530 |
Why?
|
Fumarate Hydratase | 3 | 2022 | 55 | 0.520 |
Why?
|
Angiomyolipoma | 1 | 2017 | 189 | 0.520 |
Why?
|
Terminology as Topic | 4 | 2021 | 1536 | 0.510 |
Why?
|
Oncogenes | 4 | 2023 | 1231 | 0.510 |
Why?
|
Male Urogenital Diseases | 1 | 2015 | 48 | 0.500 |
Why?
|
Neoplasms, Adnexal and Skin Appendage | 1 | 2015 | 26 | 0.490 |
Why?
|
Humans | 171 | 2024 | 766000 | 0.490 |
Why?
|
Female Urogenital Diseases | 1 | 2015 | 57 | 0.490 |
Why?
|
Predictive Value of Tests | 18 | 2022 | 15401 | 0.490 |
Why?
|
Urinary Bladder | 2 | 2020 | 1156 | 0.480 |
Why?
|
Radiotherapy | 1 | 2021 | 1491 | 0.460 |
Why?
|
Adenoma | 3 | 2021 | 2155 | 0.460 |
Why?
|
Prostate | 9 | 2022 | 1757 | 0.450 |
Why?
|
Repressor Proteins | 2 | 2023 | 2974 | 0.450 |
Why?
|
Carcinoma, Endometrioid | 3 | 2014 | 275 | 0.440 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3594 | 0.430 |
Why?
|
Trophoblasts | 1 | 2015 | 223 | 0.430 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2021 | 702 | 0.410 |
Why?
|
Pelvic Neoplasms | 4 | 2023 | 248 | 0.400 |
Why?
|
Sertoli Cell Tumor | 2 | 2023 | 35 | 0.400 |
Why?
|
Prostatectomy | 9 | 2024 | 1786 | 0.400 |
Why?
|
Female | 96 | 2024 | 396158 | 0.390 |
Why?
|
Male | 86 | 2024 | 363855 | 0.390 |
Why?
|
Neoplasm Invasiveness | 8 | 2024 | 3604 | 0.390 |
Why?
|
Adipose Tissue | 1 | 2024 | 3314 | 0.390 |
Why?
|
Neoplastic Syndromes, Hereditary | 3 | 2024 | 249 | 0.390 |
Why?
|
Seminoma | 2 | 2023 | 135 | 0.370 |
Why?
|
Mesonephroma | 2 | 2024 | 21 | 0.370 |
Why?
|
Carcinoma, Medullary | 2 | 2017 | 115 | 0.350 |
Why?
|
Lymphoma, T-Cell | 1 | 2012 | 308 | 0.340 |
Why?
|
Fallopian Tubes | 5 | 2023 | 179 | 0.330 |
Why?
|
Aged | 60 | 2024 | 171161 | 0.330 |
Why?
|
Testis | 2 | 2024 | 782 | 0.320 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2009 | 412 | 0.320 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2022 | 343 | 0.320 |
Why?
|
Melanoma | 3 | 2023 | 5695 | 0.310 |
Why?
|
Mutation | 23 | 2024 | 30208 | 0.310 |
Why?
|
Vulvar Neoplasms | 2 | 2008 | 265 | 0.310 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2022 | 8613 | 0.300 |
Why?
|
Pathology | 2 | 2021 | 270 | 0.290 |
Why?
|
Middle Aged | 60 | 2024 | 223025 | 0.280 |
Why?
|
Tumor Suppressor Protein p53 | 12 | 2022 | 2945 | 0.280 |
Why?
|
Biopsy | 12 | 2023 | 6768 | 0.280 |
Why?
|
Pyrroles | 2 | 2010 | 1120 | 0.270 |
Why?
|
Adult | 45 | 2024 | 223106 | 0.260 |
Why?
|
Skin Neoplasms | 3 | 2022 | 5836 | 0.260 |
Why?
|
Neuroendocrine Tumors | 2 | 2023 | 657 | 0.260 |
Why?
|
Lymphoma, B-Cell | 1 | 2012 | 943 | 0.250 |
Why?
|
Kidney Tubules, Collecting | 2 | 2018 | 163 | 0.250 |
Why?
|
Hysterectomy | 2 | 2010 | 864 | 0.250 |
Why?
|
Neoplasms, Glandular and Epithelial | 3 | 2016 | 488 | 0.250 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13634 | 0.250 |
Why?
|
Pleural Neoplasms | 1 | 2010 | 584 | 0.240 |
Why?
|
Cell Proliferation | 11 | 2022 | 10431 | 0.240 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2020 | 4047 | 0.240 |
Why?
|
Granulosa Cell Tumor | 2 | 2024 | 76 | 0.240 |
Why?
|
Indoles | 2 | 2010 | 1832 | 0.240 |
Why?
|
Prostate-Specific Antigen | 7 | 2022 | 2463 | 0.230 |
Why?
|
Blood Vessels | 1 | 2010 | 1113 | 0.230 |
Why?
|
Lymph Nodes | 2 | 2015 | 3457 | 0.230 |
Why?
|
Aged, 80 and over | 22 | 2024 | 59493 | 0.220 |
Why?
|
Mesothelioma | 1 | 2010 | 774 | 0.220 |
Why?
|
Practice Guidelines as Topic | 1 | 2021 | 7423 | 0.220 |
Why?
|
Soft Tissue Neoplasms | 2 | 2023 | 1163 | 0.220 |
Why?
|
Blotting, Western | 4 | 2015 | 5019 | 0.210 |
Why?
|
Neoplasms, Second Primary | 2 | 2008 | 1056 | 0.210 |
Why?
|
beta Catenin | 2 | 2021 | 1047 | 0.210 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 4 | 2024 | 1765 | 0.210 |
Why?
|
Chromosomes, Human, Pair 3 | 2 | 2008 | 322 | 0.210 |
Why?
|
Malacoplakia | 1 | 2022 | 15 | 0.210 |
Why?
|
Neoplasms, Connective and Soft Tissue | 1 | 2023 | 34 | 0.210 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2022 | 28 | 0.200 |
Why?
|
DNA Mutational Analysis | 6 | 2018 | 4112 | 0.200 |
Why?
|
Cyclic AMP-Dependent Protein Kinase RIalpha Subunit | 1 | 2022 | 24 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2014 | 2838 | 0.200 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2022 | 455 | 0.190 |
Why?
|
Neoplasm Recurrence, Local | 7 | 2023 | 9378 | 0.190 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2022 | 168 | 0.190 |
Why?
|
Spermatogonia | 1 | 2021 | 30 | 0.190 |
Why?
|
Granular Cell Tumor | 1 | 2021 | 46 | 0.190 |
Why?
|
Genes, BRCA2 | 4 | 2013 | 591 | 0.190 |
Why?
|
Leydig Cell Tumor | 1 | 2021 | 28 | 0.190 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2002 | 370 | 0.190 |
Why?
|
Artifacts | 1 | 2010 | 1896 | 0.190 |
Why?
|
Neoplasms, Multiple Primary | 3 | 2010 | 590 | 0.190 |
Why?
|
Vulvar Diseases | 1 | 2021 | 64 | 0.180 |
Why?
|
gp100 Melanoma Antigen | 1 | 2020 | 37 | 0.180 |
Why?
|
Genes, BRCA1 | 4 | 2013 | 753 | 0.180 |
Why?
|
MART-1 Antigen | 1 | 2020 | 62 | 0.180 |
Why?
|
Chorionic Gonadotropin | 1 | 2023 | 457 | 0.180 |
Why?
|
Laryngeal Neoplasms | 1 | 2004 | 514 | 0.170 |
Why?
|
Birt-Hogg-Dube Syndrome | 1 | 2020 | 40 | 0.170 |
Why?
|
Uterine Cervical Diseases | 1 | 2020 | 75 | 0.170 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2020 | 68 | 0.170 |
Why?
|
Microphthalmia-Associated Transcription Factor | 1 | 2022 | 257 | 0.170 |
Why?
|
Carcinoma, Ductal | 1 | 2020 | 97 | 0.170 |
Why?
|
Receptors, Somatostatin | 1 | 2020 | 138 | 0.170 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 2 | 2024 | 109 | 0.170 |
Why?
|
Cell Differentiation | 5 | 2021 | 11642 | 0.160 |
Why?
|
Vaginal Diseases | 1 | 2020 | 103 | 0.160 |
Why?
|
Colorectal Neoplasms | 4 | 2024 | 6961 | 0.160 |
Why?
|
Cell Nucleus | 3 | 2021 | 2864 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 6 | 2021 | 3664 | 0.160 |
Why?
|
Rhabdoid Tumor | 1 | 2021 | 209 | 0.160 |
Why?
|
Choristoma | 1 | 2020 | 205 | 0.150 |
Why?
|
Kallikreins | 1 | 2020 | 219 | 0.150 |
Why?
|
Succinate Dehydrogenase | 2 | 2021 | 148 | 0.150 |
Why?
|
Tissue Array Analysis | 4 | 2016 | 545 | 0.150 |
Why?
|
Urology | 2 | 2020 | 384 | 0.150 |
Why?
|
Chromosome Aberrations | 3 | 2024 | 1775 | 0.150 |
Why?
|
Smad4 Protein | 1 | 2019 | 194 | 0.150 |
Why?
|
Neoplasm Staging | 10 | 2021 | 11202 | 0.150 |
Why?
|
Reproducibility of Results | 8 | 2023 | 20135 | 0.150 |
Why?
|
Gadolinium DTPA | 3 | 2017 | 822 | 0.150 |
Why?
|
Retrospective Studies | 19 | 2024 | 81542 | 0.150 |
Why?
|
Alphapapillomavirus | 1 | 2020 | 219 | 0.140 |
Why?
|
Tumor Suppressor Proteins | 3 | 2022 | 2793 | 0.140 |
Why?
|
Thyroid Gland | 1 | 2004 | 1169 | 0.140 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2021 | 614 | 0.140 |
Why?
|
Gene Expression Profiling | 8 | 2021 | 9524 | 0.140 |
Why?
|
5-Methylcytosine | 1 | 2017 | 146 | 0.140 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2017 | 35 | 0.140 |
Why?
|
Cadherins | 1 | 2021 | 900 | 0.130 |
Why?
|
Gene Amplification | 4 | 2014 | 1088 | 0.130 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2022 | 1609 | 0.130 |
Why?
|
Ki-67 Antigen | 3 | 2015 | 628 | 0.130 |
Why?
|
Sarcoidosis | 1 | 2022 | 535 | 0.130 |
Why?
|
Saposins | 1 | 2016 | 22 | 0.130 |
Why?
|
Northern Ireland | 1 | 2015 | 37 | 0.130 |
Why?
|
Gene Rearrangement | 1 | 2021 | 1142 | 0.130 |
Why?
|
Magnetic Resonance Imaging | 12 | 2024 | 36545 | 0.120 |
Why?
|
Neoadjuvant Therapy | 3 | 2019 | 2897 | 0.120 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2232 | 0.120 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2019 | 958 | 0.120 |
Why?
|
Specialization | 1 | 2020 | 779 | 0.120 |
Why?
|
Histone Code | 1 | 2016 | 160 | 0.120 |
Why?
|
Hepatocyte Nuclear Factor 1-beta | 1 | 2015 | 93 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 3 | 2021 | 614 | 0.120 |
Why?
|
Germ Cells | 1 | 2018 | 646 | 0.120 |
Why?
|
Disease Progression | 6 | 2020 | 13613 | 0.120 |
Why?
|
Karyotyping | 2 | 2009 | 1175 | 0.120 |
Why?
|
Nephrectomy | 5 | 2024 | 928 | 0.120 |
Why?
|
Urogenital Neoplasms | 1 | 2015 | 130 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11858 | 0.120 |
Why?
|
S100 Proteins | 1 | 2015 | 214 | 0.110 |
Why?
|
Thrombospondin 1 | 1 | 2016 | 256 | 0.110 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2023 | 2056 | 0.110 |
Why?
|
Papillomavirus Infections | 2 | 2020 | 1637 | 0.110 |
Why?
|
Keratin-7 | 2 | 2017 | 55 | 0.110 |
Why?
|
Biological Products | 1 | 2023 | 947 | 0.110 |
Why?
|
Ubiquitination | 1 | 2018 | 1000 | 0.110 |
Why?
|
Androgen Antagonists | 1 | 2023 | 1411 | 0.110 |
Why?
|
Peptides, Cyclic | 1 | 2016 | 390 | 0.110 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2054 | 0.110 |
Why?
|
Health Resources | 1 | 2020 | 951 | 0.110 |
Why?
|
Leuprolide | 1 | 2015 | 310 | 0.110 |
Why?
|
Ovary | 1 | 2018 | 961 | 0.110 |
Why?
|
Meningioma | 1 | 2022 | 1221 | 0.110 |
Why?
|
Octamer Transcription Factor-3 | 2 | 2016 | 220 | 0.110 |
Why?
|
Observer Variation | 5 | 2021 | 2611 | 0.110 |
Why?
|
Cyclin E | 1 | 2013 | 155 | 0.110 |
Why?
|
Meningeal Neoplasms | 1 | 2022 | 1252 | 0.110 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 640 | 0.110 |
Why?
|
Prognosis | 12 | 2019 | 29904 | 0.110 |
Why?
|
Protective Agents | 1 | 2014 | 151 | 0.100 |
Why?
|
Antibodies, Monoclonal | 3 | 2020 | 9237 | 0.100 |
Why?
|
Calcinosis | 1 | 2022 | 1475 | 0.100 |
Why?
|
Young Adult | 13 | 2022 | 59857 | 0.100 |
Why?
|
Inhibitor of Differentiation Proteins | 1 | 2012 | 17 | 0.100 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 161 | 0.100 |
Why?
|
Cell Lineage | 2 | 2018 | 2574 | 0.100 |
Why?
|
Protein Kinase C | 1 | 2017 | 1205 | 0.100 |
Why?
|
Isoenzymes | 1 | 2017 | 1688 | 0.100 |
Why?
|
Racemases and Epimerases | 2 | 2021 | 113 | 0.100 |
Why?
|
Sensitivity and Specificity | 5 | 2020 | 14644 | 0.100 |
Why?
|
Antigens, CD | 2 | 2021 | 4025 | 0.100 |
Why?
|
Immunoenzyme Techniques | 3 | 2010 | 1695 | 0.090 |
Why?
|
Intestines | 1 | 2020 | 1903 | 0.090 |
Why?
|
Gene Order | 1 | 2011 | 164 | 0.090 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2014 | 633 | 0.090 |
Why?
|
Lymphatic Metastasis | 2 | 2017 | 2890 | 0.090 |
Why?
|
Cell Line, Tumor | 7 | 2016 | 17070 | 0.090 |
Why?
|
Pelvis | 1 | 2015 | 737 | 0.090 |
Why?
|
Nuclear Proteins | 2 | 2009 | 5791 | 0.090 |
Why?
|
Risk Assessment | 7 | 2021 | 24272 | 0.090 |
Why?
|
Carcinoma, Islet Cell | 1 | 2010 | 21 | 0.090 |
Why?
|
Biopsy, Needle | 3 | 2021 | 1613 | 0.090 |
Why?
|
Transcription Factors | 4 | 2023 | 12128 | 0.090 |
Why?
|
Neoplastic Stem Cells | 1 | 2018 | 1351 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2022 | 4649 | 0.090 |
Why?
|
Adenoma, Islet Cell | 1 | 2010 | 72 | 0.090 |
Why?
|
Epithelial Cells | 2 | 2020 | 3684 | 0.090 |
Why?
|
Fluorescent Antibody Technique, Direct | 1 | 2010 | 65 | 0.090 |
Why?
|
Lung Diseases | 1 | 2020 | 1941 | 0.090 |
Why?
|
Receptor, Notch1 | 1 | 2013 | 516 | 0.090 |
Why?
|
Esophageal Neoplasms | 1 | 2020 | 1659 | 0.090 |
Why?
|
Stomach Neoplasms | 1 | 2020 | 1471 | 0.090 |
Why?
|
Elafin | 1 | 2010 | 29 | 0.090 |
Why?
|
Appendectomy | 1 | 2013 | 445 | 0.090 |
Why?
|
Drug Resistance, Neoplasm | 3 | 2016 | 5334 | 0.080 |
Why?
|
Phenotype | 8 | 2022 | 16712 | 0.080 |
Why?
|
Cystectomy | 1 | 2014 | 603 | 0.080 |
Why?
|
Tumor Microenvironment | 3 | 2021 | 3942 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2013 | 711 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2014 | 2878 | 0.080 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 1105 | 0.080 |
Why?
|
Neoplasm Metastasis | 4 | 2016 | 4886 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.080 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1897 | 0.080 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2013 | 904 | 0.080 |
Why?
|
Societies, Medical | 1 | 2021 | 3955 | 0.080 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2010 | 237 | 0.080 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2012 | 335 | 0.080 |
Why?
|
Keratin-19 | 1 | 2008 | 33 | 0.080 |
Why?
|
HLA-D Antigens | 1 | 2008 | 130 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2012 | 562 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 6 | 2019 | 6506 | 0.080 |
Why?
|
Nucleic Acid Hybridization | 1 | 2010 | 1304 | 0.080 |
Why?
|
Carcinoid Tumor | 1 | 2010 | 225 | 0.080 |
Why?
|
Laparoscopy | 2 | 2010 | 2039 | 0.080 |
Why?
|
Loss of Heterozygosity | 2 | 2023 | 663 | 0.080 |
Why?
|
Ascites | 1 | 2010 | 336 | 0.080 |
Why?
|
Histones | 1 | 2018 | 2591 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2012 | 492 | 0.070 |
Why?
|
SEER Program | 1 | 2013 | 1443 | 0.070 |
Why?
|
Cytoskeletal Proteins | 2 | 2013 | 1321 | 0.070 |
Why?
|
Immune Tolerance | 1 | 2017 | 2324 | 0.070 |
Why?
|
Health Care Surveys | 3 | 2021 | 2425 | 0.070 |
Why?
|
Diffusion Magnetic Resonance Imaging | 2 | 2017 | 2806 | 0.070 |
Why?
|
Treatment Outcome | 12 | 2020 | 65199 | 0.070 |
Why?
|
Vulva | 1 | 2008 | 84 | 0.070 |
Why?
|
Contrast Media | 5 | 2024 | 5329 | 0.070 |
Why?
|
Chromosomes, Human, Pair 12 | 2 | 2023 | 432 | 0.070 |
Why?
|
Genes, p53 | 4 | 2013 | 711 | 0.070 |
Why?
|
SOXB1 Transcription Factors | 1 | 2009 | 283 | 0.070 |
Why?
|
Genomics | 5 | 2023 | 5924 | 0.070 |
Why?
|
Child | 10 | 2022 | 80567 | 0.070 |
Why?
|
Sex Factors | 1 | 2021 | 10611 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 6 | 2024 | 20698 | 0.070 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2017 | 2898 | 0.070 |
Why?
|
Boston | 3 | 2015 | 9336 | 0.070 |
Why?
|
Epigenesis, Genetic | 2 | 2017 | 3821 | 0.070 |
Why?
|
Molecular Targeted Therapy | 2 | 2016 | 2825 | 0.070 |
Why?
|
Pancreatic Neoplasms | 2 | 2018 | 5454 | 0.070 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2017 | 1801 | 0.070 |
Why?
|
Chromatin | 1 | 2018 | 2980 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 18076 | 0.070 |
Why?
|
Vaginal Neoplasms | 1 | 2007 | 105 | 0.070 |
Why?
|
Interdisciplinary Communication | 1 | 2012 | 931 | 0.070 |
Why?
|
Hernia, Ventral | 1 | 2010 | 220 | 0.070 |
Why?
|
Cervix Uteri | 1 | 2010 | 575 | 0.070 |
Why?
|
Gene Frequency | 1 | 2013 | 3623 | 0.070 |
Why?
|
Databases, Factual | 1 | 2022 | 8062 | 0.060 |
Why?
|
RNA, Messenger | 3 | 2016 | 12772 | 0.060 |
Why?
|
Time Factors | 6 | 2020 | 40100 | 0.060 |
Why?
|
Microtubules | 1 | 2011 | 1062 | 0.060 |
Why?
|
Nevus, Pigmented | 1 | 2008 | 222 | 0.060 |
Why?
|
Risk Factors | 8 | 2021 | 74838 | 0.060 |
Why?
|
Survival Analysis | 4 | 2021 | 10089 | 0.060 |
Why?
|
Brain Neoplasms | 2 | 2024 | 9064 | 0.060 |
Why?
|
Biopsy, Fine-Needle | 2 | 2024 | 1131 | 0.060 |
Why?
|
Organ Size | 1 | 2010 | 2260 | 0.060 |
Why?
|
Corpus Luteum | 1 | 2004 | 81 | 0.060 |
Why?
|
Receptors, Progesterone | 1 | 2009 | 1152 | 0.060 |
Why?
|
Prostatic Intraepithelial Neoplasia | 1 | 2004 | 80 | 0.060 |
Why?
|
Muscle Proteins | 1 | 2009 | 1160 | 0.060 |
Why?
|
Genotype | 3 | 2013 | 13029 | 0.060 |
Why?
|
Androgens | 2 | 2023 | 1278 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2016 | 3499 | 0.060 |
Why?
|
Genomic Instability | 1 | 2008 | 714 | 0.060 |
Why?
|
Homeodomain Proteins | 2 | 2012 | 2429 | 0.050 |
Why?
|
Apoptosis | 3 | 2018 | 9507 | 0.050 |
Why?
|
Chromosome Duplication | 1 | 2023 | 79 | 0.050 |
Why?
|
Genome, Human | 1 | 2016 | 4442 | 0.050 |
Why?
|
Robotics | 1 | 2010 | 807 | 0.050 |
Why?
|
Signal Transduction | 7 | 2021 | 23600 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2012 | 2744 | 0.050 |
Why?
|
Epithelium | 3 | 2013 | 1604 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2013 | 2234 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3423 | 0.050 |
Why?
|
Calcitonin | 1 | 2004 | 326 | 0.050 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2024 | 194 | 0.050 |
Why?
|
Mitochondria | 2 | 2016 | 3675 | 0.050 |
Why?
|
Methotrexate | 2 | 2023 | 1719 | 0.050 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2015 | 3359 | 0.050 |
Why?
|
Medical Errors | 1 | 2010 | 1260 | 0.050 |
Why?
|
Orchiectomy | 1 | 2024 | 465 | 0.050 |
Why?
|
MutS Homolog 2 Protein | 1 | 2022 | 200 | 0.050 |
Why?
|
NF-kappa B | 1 | 2010 | 2495 | 0.050 |
Why?
|
Receptors, Estrogen | 1 | 2009 | 2242 | 0.050 |
Why?
|
Neurofibromin 2 | 1 | 2022 | 268 | 0.050 |
Why?
|
Nucleotides | 1 | 2023 | 454 | 0.050 |
Why?
|
Patient Care Team | 1 | 2012 | 2517 | 0.050 |
Why?
|
Specimen Handling | 2 | 2020 | 704 | 0.050 |
Why?
|
Long Interspersed Nucleotide Elements | 1 | 2023 | 332 | 0.040 |
Why?
|
Genetic Heterogeneity | 1 | 2024 | 735 | 0.040 |
Why?
|
Nanoparticles | 1 | 2012 | 1965 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2019 | 6840 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2016 | 856 | 0.040 |
Why?
|
BCG Vaccine | 1 | 2023 | 381 | 0.040 |
Why?
|
Neprilysin | 1 | 2003 | 484 | 0.040 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 2171 | 0.040 |
Why?
|
Keratins | 1 | 2021 | 496 | 0.040 |
Why?
|
Granuloma | 1 | 2022 | 329 | 0.040 |
Why?
|
Adnexa Uteri | 1 | 2019 | 40 | 0.040 |
Why?
|
Sequence Analysis, RNA | 2 | 2018 | 2038 | 0.040 |
Why?
|
Telomerase | 1 | 2024 | 749 | 0.040 |
Why?
|
Gene Fusion | 1 | 2022 | 357 | 0.040 |
Why?
|
DNA Mismatch Repair | 1 | 2022 | 432 | 0.040 |
Why?
|
DNA Copy Number Variations | 2 | 2018 | 2043 | 0.040 |
Why?
|
Alleles | 3 | 2017 | 6892 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2018 | 6101 | 0.040 |
Why?
|
Receptor, erbB-2 | 1 | 2009 | 2593 | 0.040 |
Why?
|
Adolescent | 8 | 2022 | 88808 | 0.040 |
Why?
|
Aneuploidy | 1 | 2022 | 573 | 0.040 |
Why?
|
Follow-Up Studies | 3 | 2015 | 39233 | 0.040 |
Why?
|
Models, Biological | 1 | 2015 | 9446 | 0.040 |
Why?
|
Hyperplasia | 1 | 2021 | 1142 | 0.040 |
Why?
|
Cohort Studies | 4 | 2015 | 41675 | 0.040 |
Why?
|
Membrane Glycoproteins | 1 | 2009 | 3692 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2017 | 3605 | 0.040 |
Why?
|
Tumor Burden | 2 | 2015 | 1889 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2022 | 559 | 0.040 |
Why?
|
Omentum | 1 | 2019 | 167 | 0.040 |
Why?
|
Microsatellite Instability | 1 | 2022 | 726 | 0.040 |
Why?
|
Online Systems | 1 | 2019 | 181 | 0.040 |
Why?
|
Mitosis | 1 | 2023 | 1175 | 0.040 |
Why?
|
Mice | 8 | 2017 | 81821 | 0.040 |
Why?
|
Necrosis | 1 | 2021 | 1614 | 0.040 |
Why?
|
Mullerian Ducts | 1 | 2018 | 203 | 0.030 |
Why?
|
Epigenomics | 1 | 2023 | 959 | 0.030 |
Why?
|
Mitotic Index | 1 | 2017 | 160 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5744 | 0.030 |
Why?
|
Muscles | 1 | 2021 | 1576 | 0.030 |
Why?
|
Fibronectins | 1 | 2020 | 721 | 0.030 |
Why?
|
Proportional Hazards Models | 4 | 2014 | 12530 | 0.030 |
Why?
|
Transsexualism | 1 | 2020 | 210 | 0.030 |
Why?
|
Cyclization | 1 | 2016 | 59 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 2 | 2013 | 1117 | 0.030 |
Why?
|
Animals | 10 | 2017 | 168775 | 0.030 |
Why?
|
Early Detection of Cancer | 1 | 2010 | 3236 | 0.030 |
Why?
|
DNA Methylation | 2 | 2022 | 4426 | 0.030 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5365 | 0.030 |
Why?
|
Doxorubicin | 2 | 2014 | 2226 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1623 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2021 | 997 | 0.030 |
Why?
|
Dioxygenases | 1 | 2017 | 354 | 0.030 |
Why?
|
Microfilament Proteins | 2 | 2013 | 1130 | 0.030 |
Why?
|
Whole Body Imaging | 1 | 2017 | 281 | 0.030 |
Why?
|
Paraffin Embedding | 1 | 2016 | 302 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2016 | 245 | 0.030 |
Why?
|
Palliative Care | 1 | 2010 | 3639 | 0.030 |
Why?
|
Neoplasms | 2 | 2016 | 22336 | 0.030 |
Why?
|
Morphogenesis | 1 | 2018 | 743 | 0.030 |
Why?
|
Hormone Replacement Therapy | 1 | 2020 | 752 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1326 | 0.030 |
Why?
|
Pathology, Clinical | 1 | 2018 | 374 | 0.030 |
Why?
|
Formaldehyde | 1 | 2016 | 360 | 0.030 |
Why?
|
Endometriosis | 1 | 2003 | 869 | 0.030 |
Why?
|
Chromosome Mapping | 1 | 2002 | 4616 | 0.030 |
Why?
|
Filgrastim | 1 | 2014 | 132 | 0.030 |
Why?
|
Australia | 1 | 2018 | 1260 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1248 | 0.030 |
Why?
|
Chemotherapy, Adjuvant | 2 | 2014 | 3546 | 0.030 |
Why?
|
Data Mining | 1 | 2018 | 560 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2021 | 7599 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2024 | 5301 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 30227 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16039 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3796 | 0.030 |
Why?
|
Prospective Studies | 4 | 2023 | 54797 | 0.030 |
Why?
|
Morpholines | 1 | 2016 | 584 | 0.030 |
Why?
|
Vinblastine | 1 | 2014 | 482 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2012 | 12061 | 0.030 |
Why?
|
DNA-Binding Proteins | 3 | 2017 | 9600 | 0.030 |
Why?
|
Canada | 1 | 2018 | 2120 | 0.030 |
Why?
|
Cell Cycle Proteins | 2 | 2017 | 3436 | 0.020 |
Why?
|
Aminopyridines | 1 | 2016 | 576 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4565 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2015 | 524 | 0.020 |
Why?
|
Subcutaneous Tissue | 1 | 2012 | 131 | 0.020 |
Why?
|
Phosphorylation | 2 | 2013 | 8290 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2018 | 1755 | 0.020 |
Why?
|
Endonucleases | 1 | 2014 | 372 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 373 | 0.020 |
Why?
|
Integrases | 1 | 2013 | 520 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2016 | 22334 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3200 | 0.020 |
Why?
|
Europe | 1 | 2018 | 3428 | 0.020 |
Why?
|
Child, Preschool | 3 | 2022 | 42509 | 0.020 |
Why?
|
Marital Status | 1 | 2012 | 426 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 1603 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1677 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2011 | 292 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2014 | 818 | 0.020 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2012 | 505 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6057 | 0.020 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2011 | 314 | 0.020 |
Why?
|
Health Surveys | 1 | 2020 | 4054 | 0.020 |
Why?
|
PAX2 Transcription Factor | 1 | 2010 | 86 | 0.020 |
Why?
|
Cell Polarity | 1 | 2013 | 636 | 0.020 |
Why?
|
Referral and Consultation | 2 | 2013 | 3617 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2010 | 0.020 |
Why?
|
Desmin | 1 | 2009 | 99 | 0.020 |
Why?
|
Genes, p16 | 1 | 2010 | 157 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2013 | 658 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1211 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1711 | 0.020 |
Why?
|
Permeability | 1 | 2011 | 726 | 0.020 |
Why?
|
Testosterone | 1 | 2020 | 2495 | 0.020 |
Why?
|
Gene Expression | 2 | 2014 | 7581 | 0.020 |
Why?
|
Histocytochemistry | 1 | 2010 | 695 | 0.020 |
Why?
|
Microdissection | 1 | 2009 | 150 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2838 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2014 | 1777 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3227 | 0.020 |
Why?
|
Matrix Metalloproteinase 14 | 1 | 2008 | 59 | 0.020 |
Why?
|
Polyethylene Glycols | 1 | 2014 | 1189 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2445 | 0.020 |
Why?
|
Evolution, Molecular | 1 | 2016 | 1889 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2010 | 1546 | 0.020 |
Why?
|
Proteins | 1 | 2023 | 5994 | 0.020 |
Why?
|
Cisplatin | 1 | 2014 | 1654 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2010 | 684 | 0.020 |
Why?
|
Cytogenetic Analysis | 1 | 2008 | 270 | 0.020 |
Why?
|
Maximum Tolerated Dose | 1 | 2010 | 895 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2015 | 7850 | 0.020 |
Why?
|
Disease Models, Animal | 2 | 2017 | 18314 | 0.020 |
Why?
|
Mice, Nude | 1 | 2014 | 3610 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2018 | 3606 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2012 | 1241 | 0.020 |
Why?
|
DNA Primers | 1 | 2011 | 2823 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2535 | 0.020 |
Why?
|
DNA Repair Enzymes | 1 | 2008 | 342 | 0.020 |
Why?
|
Computational Biology | 1 | 2018 | 3563 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6324 | 0.020 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2007 | 348 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2009 | 696 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2014 | 22231 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4853 | 0.020 |
Why?
|
ROC Curve | 1 | 2014 | 3614 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5775 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2017 | 4342 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 723 | 0.020 |
Why?
|
Random Allocation | 1 | 2010 | 2394 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2017 | 8524 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2413 | 0.020 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2013 | 949 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13482 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2008 | 751 | 0.020 |
Why?
|
Ultrasonography | 2 | 2012 | 5988 | 0.020 |
Why?
|
Protein Kinase Inhibitors | 1 | 2022 | 5695 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2017 | 4520 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2012 | 3089 | 0.020 |
Why?
|
Recurrence | 1 | 2017 | 8494 | 0.020 |
Why?
|
Cell Movement | 1 | 2017 | 5194 | 0.020 |
Why?
|
Cytoplasm | 1 | 2009 | 1498 | 0.020 |
Why?
|
Immunotherapy | 1 | 2021 | 4746 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4779 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 1406 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2014 | 2590 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2017 | 9536 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6492 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2008 | 2469 | 0.010 |
Why?
|
Image Enhancement | 1 | 2015 | 2857 | 0.010 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2197 | 0.010 |
Why?
|
Incidental Findings | 1 | 2009 | 698 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2012 | 1727 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2008 | 839 | 0.010 |
Why?
|
Islets of Langerhans | 1 | 2010 | 1349 | 0.010 |
Why?
|
Quinazolines | 1 | 2010 | 1366 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2010 | 1273 | 0.010 |
Why?
|
Radiography | 1 | 2014 | 6943 | 0.010 |
Why?
|
Algorithms | 2 | 2015 | 14065 | 0.010 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2007 | 853 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2504 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2010 | 21072 | 0.010 |
Why?
|
Exons | 1 | 2008 | 2392 | 0.010 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 1559 | 0.010 |
Why?
|
Inflammation | 1 | 2022 | 10857 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1242 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7425 | 0.010 |
Why?
|
Myometrium | 1 | 2003 | 174 | 0.010 |
Why?
|
Angiogenesis Inhibitors | 1 | 2012 | 2046 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2012 | 2627 | 0.010 |
Why?
|
Computer Simulation | 1 | 2015 | 6254 | 0.010 |
Why?
|
RNA Interference | 1 | 2010 | 2825 | 0.010 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1610 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2017 | 6544 | 0.010 |
Why?
|
Gene Deletion | 1 | 2008 | 2667 | 0.010 |
Why?
|
Patient Selection | 1 | 2012 | 4249 | 0.010 |
Why?
|
Odds Ratio | 1 | 2012 | 9655 | 0.010 |
Why?
|
Endometrium | 1 | 2003 | 404 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2011 | 5125 | 0.010 |
Why?
|
Infant | 1 | 2021 | 36424 | 0.010 |
Why?
|
Quality of Life | 1 | 2019 | 13463 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12821 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13272 | 0.010 |
Why?
|
Comorbidity | 1 | 2012 | 10577 | 0.010 |
Why?
|
Trans-Activators | 1 | 2007 | 2849 | 0.010 |
Why?
|
Stromal Cells | 1 | 2003 | 1332 | 0.010 |
Why?
|
United States | 2 | 2018 | 72916 | 0.010 |
Why?
|
Kidney | 1 | 2012 | 7070 | 0.010 |
Why?
|
MicroRNAs | 1 | 2012 | 3787 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3636 | 0.010 |
Why?
|
Age Factors | 1 | 2012 | 18382 | 0.010 |
Why?
|
Postmenopause | 1 | 2004 | 2517 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3954 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2010 | 4354 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2011 | 5189 | 0.010 |
Why?
|
Prevalence | 1 | 2010 | 15820 | 0.010 |
Why?
|